Transplant outcomes in bone marrow failure syndromes and hemoglobinopathies

Seminars in Hematology
Margaret L MacMillanE Gluckman

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only potential cure for most bone marrow (BM) failure syndromes and hemoglobinopathies. Over the past decade, umbilical cord blood (UCB) has been used more frequently as a stem cell source in patients who lack a suitable BM donor. Although graft failure remains a significant problem, UCB transplantation (UCBT) using the optimal conditioning regimen can be a salvage treatment for patients without a suitable BM donor and warrants evaluation in further prospective studies.

References

Sep 20, 1984·The New England Journal of Medicine·F L JohnsonF T Billings
Aug 1, 1980·British Journal of Haematology·E GluckmanJ Bernard
Dec 12, 1996·The New England Journal of Medicine·K L Rehman
Oct 29, 1998·British Journal of Haematology·V RochaE Gluckman
Nov 26, 1998·The New England Journal of Medicine·P RubinsteinC E Stevens
Mar 20, 1999·Bone Marrow Transplantation·A GhavamzadehG Ghahremani
Jun 11, 1999·Journal of Pediatric Hematology/oncology·M AkerA Nagler
Aug 6, 2000·British Journal of Haematology·A LacknerB Kremens
Nov 25, 2000·British Journal of Haematology·C A SieffD G Nathan
Jun 1, 2002·Bone Marrow Transplantation·Y BertrandW Friedrich
Jul 20, 2002·Blood·John MilledgeJohn Christodoulou
Nov 9, 2002·Blood·Franco LocatelliUNKNOWN Eurocord Transplant Group
Aug 22, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Robert IannoneMark C Walters
Mar 31, 2004·Experimental Hematology·Eliane GluckmanUNKNOWN Eurocord Group
Jul 13, 2004·Bone Marrow Transplantation·T V AdamkiewiczA M Yeager
Apr 23, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Tang-Her JaingRobert Chow
May 10, 2007·Haematologica·Sébastien MauryUNKNOWN French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Aug 19, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Eliane GluckmanUNKNOWN Eurocord-Netcord and EBMT
Nov 21, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Carmem M BonfimRicardo Pasquini
Mar 1, 2008·British Journal of Haematology·Fernando O Pinto, Irene Roberts
Aug 13, 2008·Bone Marrow Transplantation·K W ChanD A Wall
Aug 14, 2008·British Journal of Haematology·A RuggeriG Socié
Aug 30, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ayami YoshimiUNKNOWN Japan Cord Blood Bank Network (JCBBN)

❮ Previous
Next ❯

Citations

Dec 22, 2012·Journal of Biomedicine & Biotechnology·Somayeh ShahrokhiMassoumeh Ebtekar
Apr 21, 2012·Blood·Phillip Scheinberg, Neal S Young
Apr 2, 2010·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Paolo Rebulla
Sep 16, 2010·Annals of the New York Academy of Sciences·Xiao Yan ZhongWolfgang Holzgreve
Jan 18, 2011·Hematology·Mary Eapen, Mary M Horowitz
May 19, 2019·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Eman F BoteinAli M Shaltot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Seminars in Hematology
Vinod K Prasad, Joanne Kurtzberg
© 2021 Meta ULC. All rights reserved